📦 ✨ The fastest, non-invasive solution to detect myocardial ischemia.

The standard of care for
ischemic heart disease has changed.

Detect functionally significant ischemia at its earliest stages - all in as little as 5 minutes - with the world’s first clinically ready MCG machine.

CardioFlux Partners

Old Meets New

Trusted science meets
brand new technology.

Magnetocardiography is the science that enables CardioFlux to measure the natural magnetic fields produced by the heart. We’re bringing 40 years of proven science into the heart of hospital workflows by improving the most limiting aspects of the technique.

More about MCG →

CardioFlux promises diagnostic
certainty without the burden.

Significantly earlier detection of chest pain patients means less time testing - and more time treating -
underlying disease.

Without CardioFlux

An ECG and initial troponin draw are taken.

A second troponin test is taken and results are compared with the first.

Downstream testing often requires waiting hours for technician availability and cardiology review.

Based on symptoms and risk factors, patients are often kept in an obs unit overnight before being sent home.

Stress testing requires 90 minutes to prepare and complete in a stress lab.

Although sent home, chest pain patients are often left with "inconclusive" results and "atypical" symptoms, often repeating the process of seeking a diagnosis in the near future.

With CardioFlux

An initial ECG and troponin draw are taken.

A CardioFlux scan is performed in five minutes and requires no stress.

A second troponin test is taken and results are compared with the first.


If necessary, a diagnosis is made. With fewer tests and less time spent waiting, efficient diagnosis means more effective triage and earlier discharge for chest pain patients.

Sign up for our newsletter.

Stay up to date with the lastest & greatest in cardiac imaging.

"We operate with a specific vision of the future in mind and are working tirelessly to provide efficient, patient-centric, and highly insightful biomagnetic solutions to solve some of the world’s most pressing healthcare challenges.”

Vineet Erasala

Co-Founder, COO

"With improved sensing, next-generation computing, and a good team committed to meeting clinical needs that weren't even known at the time the technology was originally conceived, we knew we had an opportunity to bring this technology to the forefront."

Peeyush Shrivastava

Genetesis Co-Founder, CEO


Don't take our word for it.
Hear from physicians.

Over and over, physicians keep saying CardioFlux is the non-invasive functional test that they have been searching for.

Partnering with Us →
‍“[CardioFlux] will cut down the patient’s length of stay, cost to hospitals and it will be safer because it could cut down on risks like hospital acquired infections, radioactive dye and potential treadmill injury.”

Dr. Margarita Pena, MD, FACEP

Observation Unit, Ascension St. John Hospital

“The [Breakthrough] process combined with reimbursement policy as part of the CardioFlux FDA Pathway will provide immediate access to this safe, noninvasive and radiation-free diagnostic technology for our patients.”

Dr. Simon Mahler, MD, MS, FACEP

Emergency Medicine Physician and Professor at Wake Forest Baptist Health

“CardioFlux is in a unique position to rule out myocardial ischemia in an emergency room scenario, since the rapid test requires no contact with the patient, no IV, no injection and can be performed with social distancing. This is what we need now.”

Dr. Randall Wolf, MD, FACC

Cardiothoracic Surgeon at Houston Methodist Hospital

"The benefits of CardioFlux are numerous including reduction in cost and necessary radiation, shortening length of stay and increasing convenience without compromising safety."

Dr. Robert Takla

Medical Director & Chair of Emergency Medicine, Ascension St. John Hospital

"While previous studies of magnetocardiography have yielded promise in the detection of coronary artery disease, this is the first time a scalable iteration of this technology has been made available to emergency medicine in their difficult task of diagnosing ACS."

Dr. Alisa Niksch

Pediatric Cardiologist at Tufts Medical Center

Genetesis Press

CardioFlux is revolutionizing the healthcare space, by unlocking the body’s hidden potential.

Our News Mentions →